Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Business Officer

Chief Scientific Officer

Ikena Oncology, Inc. operates as an oncology company that develops precision medicines to biomarker-defined patients with specific unmet needs in the United States. Its lead oncology product candidate is IK-930, a paralog selective inhibitor of the transcriptional enhanced associate domain, a transcription factor in the Hippo signaling pathway. It also develops IK-595, designed to trap MEK and RAF for inhibiting RAS signals than existing inhibitors; and IK-175, a monotherapy and in combination with nivolumab in patients with advanced or metastatic solid tumors, including urothelial carcinomas. Ikena Oncology, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Ikena Oncology, Inc. operates as an oncology company that develops precision medicines to biomarker-defined patients with specific unmet n...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-08-04	Premium	acquired	Premium	Premium	Premium	-
2023-08-04	Premium	acquired	Premium	Premium	Premium	-
2022-06-24	Premium	bought	Premium	Premium	Premium	-
2022-06-24	Premium	bought	Premium	Premium	Premium	-
2022-06-23	Premium	bought	Premium	Premium	Premium	-
2022-06-23	Premium	bought	Premium	Premium	Premium	-
2022-06-22	Premium	bought	Premium	Premium	Premium	-
2022-06-22	Premium	bought	Premium	Premium	Premium	-
2022-01-18	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2022-01-11	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-01-11	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2022-01-10	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-01-10	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2021-12-14	Premium	sold	Premium	Premium	Premium	-
2021-12-14	Premium	sold	Premium	Premium	Premium	-
2021-12-13	Premium	sold	Premium	Premium	Premium	-
2021-12-13	Premium	sold	Premium	Premium	Premium	-
2021-12-10	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2021-12-10	Premium	sold	Premium	Premium	Premium	-
2021-12-10	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2021-12-10	Premium	sold	Premium	Premium	Premium	-
2021-03-30	Premium	bought	Premium	Premium	Premium	-
2021-03-30	Premium	acquired	Premium	Premium	Premium	-

IKNA - Ikena Oncology, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for IKNA